Metabolite Profiling of Lavender (Lavandula pedunculata subsp. cariensis) Essential Oil and Investigation of Its Potential Antioxidant and Enzyme-Inhibitory Effects

Abstract

Background/Objectives: Lavandula cariensis species is cultivated uncommonly in the western region of Turkey. The colloquial appellations avayianos, karabasi, and myra are used to refer to the L. cariensis plant. The essential oil of L. cariensis was studied for its potential antiglaucoma, antioxidant, antidiabetic, and acetylcholinesterase inhibitory effects. Methods: The inhibitory effect of the essential oil of L. cariensis on the acetylcholinesterase (AChE), carbonic anhydrase II (CA II), and alpha-amylase enzymes was determined. Therefore, chemical profiles of L. cariensis' essential oil were identified using Gas Chromatography Mass Spectrometry (GC-MS) and as Chromatography with Flame Ionization Detection (GC-FID) analyses. Results: Camphor (39.73%), fenchone (19.49%), exobornyl acetate (6.81%), camphene (5.49%), and eucalyptol (5.49%) were the most abundant compounds in L. cariensis essential oil. Radical scavenging effect of the essential oil of L. cariensis was examined using 1,1-diphenyl-2-picrylhydrazyl (DPPH) (IC50: 231.0 +/- 0.094 mu g/mL) and 2,2 '-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) (IC50: 7.45 +/- 0.013 mu g/mL) radicals. Also, the ferric ions (Fe3+), cupric ions (Cu2+), and Fe3+-2,4,6-tri(2-pyridyl)-S-triazine (TPTZ) complex reducing capabilities were studied. Additionally, essential oil of L. cariensis indicated a comparable level of inhibition towards hCA II (IC50: 276.42 mu g/mL), AChE (IC50: 14.22 mu g/mL), and alpha-amylase (IC50: 475.63 mu g/mL) enzymes. Conclusions: The evaluation of the antioxidant capabilities and enzyme inhibition profiling of the essential oil of L. cariensis will be made possible by this comprehensive study, which serves as a springboard for further research. The essential oil of L. cariensis demonstrated enzyme-inhibitory activities against target enzymes associated with Alzheimer's disease, diabetes, and glaucoma. Also, this study's in vitro inhibition suggests promising prospects.